• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

Yinhua CNI HK Connect Innovative Drugs ETF(159567.SZ)

Last Updated 00:00:00
longbridge loading
News
Holdings
Overview
Company Encyclopedia
View More
name
Yinhua CNI HK Connect Innovative Drugs ETF
159567.SZ
Shareholder
Ownership%OwnedShare ChgReport Date
No Data
News
View More

Everest Medicines Signs Lease Agreement for New Premises

Everest Medicines Limited has signed a lease agreement through its subsidiary, Everest Medicines Trading (Shanghai) Co., Ltd., with Kang Pu as the lessor. The agreement involves leasing certain premises for a specified term. Mr. Wei Fu, a non-executive director with a material interest in the transaction, abstained from voting on the board resolutions. The company confirmed compliance with the Hong Kong Listing Rules regarding necessary approvals.

Reuters·01/26/2026 22:01
Reuters·01/26/2026 22:01
© 2026 Longbridge|Disclaimer

Event Tracking

Jan29
Stone Pharmaceutical's In-body CAR-T Product SYS6055 Approved for Clinical Trials by NMPA
11:47
CMB Analyst Reiterates Buy Rating for 3SBio with Target Price
05:13
Pfizer and Sino Legend Biopharmaceuticals Advance PD-1/VEGF Bispecific Antibody Development
02:49
Jan27
China BioPharm Ltd. Announces Positive Phase II Clinical Trial Results for TQA3605 in Chronic Hepatitis B Treatment
08:31
Innovent IBI3003 Receives FDA Fast Track Designation
00:12
Jan26
Hanson Pharmaceutical Plans to Raise HK$4.68 Billion Through Convertible Bonds
22:16